Elsbernd Brian 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Elsbernd Brian
Chief Compliance/Legal Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-12-08+7,067→ 241,237 total - Tax Payment
Common Stock, par value $0.001 per share
2025-12-08−2,780→ 238,457 total - Exercise/Conversion
Restricted Stock Units
2025-12-08−7,067→ 962,809 total→ Common Stock (7,067 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025, and 1/3rd on December 8, 2026.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025.